Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

2 May 2013 07:00

RNS Number : 8051D
Sopheon PLC
02 May 2013
 



Thursday 2 May 2013

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

INTERIM MANAGEMENT STATEMENT AND CAPITAL REORGANISATION

 

Sopheon plc, the internationalprovider of software and services that improve the financial return from innovation and product development investments, announces its first interim management statement for the period from1 January 2013 to the date of this announcement.

 

Building on 2012's strong performance, revenue visibility for the 2013 full year from contracted business and recurring revenue streams stands at £7.4 million, compared to £6.5 million a year ago. In addition to the maintenance base and some early license wins, much of the visibility relates to ongoing service projects; the first quarter saw a lot of activity with new license opportunities from a mix of new and existing customers, which we are now starting to close during the second quarter.

 

We have continued our recruitment efforts and since the start of the year have added staff in a number of areas, most notably in our European marketing team. This continues our steady expansion of commercial resources in the territory over the last year. Nevertheless we continue to watch revenue performance very closely, given that global markets continue to lack consistency and prediction of the timing and value of individual sales remains challenging.

 

A major product milestone was achieved with the release of Accolade® 8.2, the latest version of our flagship software solution. With this release, businesses are able, for the first time, to access "a single source of the truth" from a fully-integrated solution across the entire innovation management and new product development lifecycle. New features have been added in a range of areas including Portfolio Management, Innovation Planning and Resource Planning. In addition, support has been extended for project teams, extended search and classification, mass import functionality, international languages, and more efficient IT installation, operations, integration and maintenance capabilities. Further details of this milestone release are described in our announcements of 23 January 2013.

 

Capital Reorganisation

 

Notice of Sopheon's forthcoming Annual General Meeting, to be held at the offices of Squire Sanders (UK) LLP, 7 Devonshire Square, London EC2M 4YH at 11:00am on 12 June 2013 is now available on the Sopheon website, along with a circular that describes proposals for a capital reorganisation, to be put to shareholders in a general meeting of the Company to be held immediately after the Annual General Meeting. 

 

As we have previously stated, the goals of the restructuring include consolidating the number of shares, and reducing the accumulated deficit on the profit and loss account. To that end, the Company is proposing a 10000:1 share consolidation that creates Interim Ordinary Shares of £500 each, followed by a subdivision of 1:500 that creates subdivided ordinary shares of £1 each, and finally a re-designation to reduce the nominal value of the resultant ordinary shares to 20p per New Ordinary Share. The Company is also seeking approval to undertake a capital reduction in order to reduce the deficit on its profit and loss account.

 

The proposed timetable for the reorganisation is given below. Due to differences in the settlement mechanisms between the Netherlands and the UK, the record date set out in the proposed timetable for shares in the Netherlands is three days later than in the UK. This is the reason for the one week gap between the Share Consolidation and the Share Subdivision. Notwithstanding the foregoing, trading in the Interim Ordinary Shares will commence on both AIM and Alternext on 17 June 2013, and trading in the New Ordinary Shares will commence on both AIM and Alternext on 24 June 2013.

 

Full details of the proposed reorganisation, including definitions of capitalised terms not defined in this announcement, can be found in the circular.

 

 

Latest time and date for receipt of Proxy Forms

11.30 a.m. on 10 June 2013

General Meeting

11.30am on 12 June 2013

UK Record Date for the Share Consolidation

5.00 p.m. on 14 June 2013

Existing Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 14 June 2013

Admission effective and dealings commence on AIM and Alternext in Interim Ordinary Shares of £500 each

8.00 a.m. on 17 June 2013

CREST accounts credited with Interim Ordinary Shares

17 June 2013

Netherlands Record Date for Share Consolidation

19 June 2013

UK Record Date for Share Subdivision

5.00 p.m. on 21 June 2013

Interim Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 21 June 2013

Admission effective and dealings in New Ordinary Shares commence on AIM and Alternext in New Ordinary Shares of 20p each

8.00 a.m. 24 June 2013

CREST accounts credited with New Ordinary Shares

24 June 2013

Netherlands Record Date for Share Subdivision

26 June 2013

New Share certificates dispatched on or before

1 July 2013

Anticipated date for Reduction of Capital - not later than

31 December 2013

 

 

Accolade® is a registered trademark of Sopheon plc.

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKSFEDXDEFF
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.